
|Articles|November 1, 2002
Hyperopia clinical module submitted to FDA
Fremont, CA-Nidek Inc. has submitted its hyperopia PMA clinical module to the FDA for review and approval of its EC-5000 Excimer Laser System for hyperopia, hyperopic astigmatism, and mixed astigmatism. This marks the final step in gaining commercialization approval by the FDA to market and treat indications of hyperopia with the Nidek system.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
2
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
3
Collarettes common but largely stable in moderate-to-severe dry eye patients
4
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
5

















































.png)


